Business Context and Reporting Period
Company: James Hardie Industries plc
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of June 2019
Filing Date: June 13, 2019
Principal Executive Offices: Dublin, Ireland
This filing serves as a notification of a change in substantial holding (Exhibit 99.1). It does not contain a full financial report or operational results for the period.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding ownership changes rather than a financial performance report.
Material Changes
Ownership Change: The filing discloses a "Change in substantial holding" as detailed in Exhibit 99.1. Specific details regarding the magnitude or nature of this change are not included in the provided text.
Guidance, Outlook, and Risks
Forward-Looking Statements: The document contains an extensive disclaimer regarding forward-looking statements. These statements cover future performance, capital expenditure, credit facilities, dividends, and tax structures.
Key Risks Identified:
- Asbestos Liabilities: Risks related to prior asbestos manufacturing, contributions to the Asbestos Injuries Compensation Fund (AICF), and potential shortfalls.
- Legal and Regulatory: Exposure to product liability, environmental, and consumer class action proceedings.
- Economic Conditions: Dependence on US and Asia Pacific housing markets, new home construction, and renovation levels.
- Operational: Supply and cost of raw materials, currency exchange risks, and integration of the Fermacell business.
- Financial: Ability to renew credit facilities and manage warranty provisions.
Investor Verification Checklist
- Review Exhibit 99.1 (not included in this text) for specific details on the change in substantial holding.
- Consult the most recent Form 20-F (filed May 21, 2019) for detailed financial metrics and risk factors referenced in this filing.
- Monitor updates regarding the Asbestos Injuries Compensation Fund (AICF) and associated liabilities.
- Verify the status of the Fermacell integration and its impact on operations.